Your browser doesn't support javascript.
loading
Letter to the editor: 1-year clinical outcomes of bivalirudin vs. unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention.
Rajab, Fatima; Mujahid, Aleena; Naseer, Bisal.
Affiliation
  • Rajab F; King Edward Medical University, Neela gumbad, Anarkali, Lahore, Pakistan.
  • Mujahid A; King Edward Medical University, Neela gumbad, Anarkali, Lahore, Pakistan.
  • Naseer B; King Edward Medical University, Neela gumbad, Anarkali, Lahore, Pakistan.
Eur Heart J Cardiovasc Pharmacother ; 10(3): 263-264, 2024 May 04.
Article in En | MEDLINE | ID: mdl-38285615
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Recombinant Proteins / Heparin / Antithrombins / Hirudins / Diabetes Mellitus, Type 2 / Percutaneous Coronary Intervention Limits: Humans Language: En Journal: Eur Heart J Cardiovasc Pharmacother Year: 2024 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Recombinant Proteins / Heparin / Antithrombins / Hirudins / Diabetes Mellitus, Type 2 / Percutaneous Coronary Intervention Limits: Humans Language: En Journal: Eur Heart J Cardiovasc Pharmacother Year: 2024 Document type: Article Affiliation country: Country of publication: